{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:15:32Z","timestamp":1790018132878,"version":"4.0.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T00:00:00Z","timestamp":1517875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Department of Veterans Affairs [Merit Reviews"},{"name":"Senior Research Career Scientist Award (JKY)]"},{"name":"VA Pittsburgh Healthcare System"},{"name":"National Institute of Health","award":["MH58141 (JKY)"],"award-info":[{"award-number":["MH58141 (JKY)"]}]},{"name":"National Institute of Health","award":["MH64023 (MK)"],"award-info":[{"award-number":["MH64023 (MK)"]}]},{"name":"National Institute of Health","award":["KO2 MH 01180"],"award-info":[{"award-number":["KO2 MH 01180"]}]},{"name":"National Institute of Health","award":["MH45156"],"award-info":[{"award-number":["MH45156"]}]},{"name":"Nature Science Foundation of China","award":["NSFC81401113 (HLC)"],"award-info":[{"award-number":["NSFC81401113 (HLC)"]}]},{"name":"Higher Education of China","award":["SRFDP20130162120060"],"award-info":[{"award-number":["SRFDP20130162120060"]}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation of China","doi-asserted-by":"crossref","award":["2017JJ3444"],"award-info":[{"award-number":["2017JJ3444"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Chinese Scholarship Council for oversea study program"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.psyneuen.2018.02.004","type":"journal-article","created":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T13:27:43Z","timestamp":1518010063000},"page":"43-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Pregnenolone-progesterone-allopregnanolone pathway as a potential therapeutic target in first-episode antipsychotic-na\u00efve patients with schizophrenia"],"prefix":"10.1016","volume":"90","author":[{"given":"HuaLin","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George G.","family":"Dougherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravinder D.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen L.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra M.","family":"Montrose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matcheri","family":"Keshavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey K.","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2018.02.004_bib0005","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1982.04290070025006","article-title":"Negative v positive schizophrenia. Definition and validation","volume":"39","author":"Andreasen","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0010","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/sj.bjp.0701046","article-title":"The effects of inhibitors of GABAergic transmission and stress on brain and plasma allopregnanolone concentrations","volume":"120","author":"Barbaccia","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0015","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0893-133X(01)00254-8","article-title":"Clozapine but not haloperidol, increases brain concentrations of neuroactive steroids in the rat","volume":"25","author":"Barbaccia","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0020","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1210\/jc.2008-1902","article-title":"The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men","volume":"94","author":"Brambilla","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0025","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/0024-3205(92)90563-5","article-title":"The effects of metabolic stress on plasma progesterone in healthy volunteers and schizophrenic patients","volume":"51","author":"Breier","year":"1992","journal-title":"Life Sci."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0030","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jchromb.2013.06.031","article-title":"Multiplexed analysis of steroid hormones in human serum using novel microflow tile technology and LC-MS\/MS","volume":"934","author":"Broccardo","year":"2013","journal-title":"J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0035","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.pnpbp.2010.07.006","article-title":"Elevated plasma \u03b3-aminobutyrate\/glutamate ratio and responses to risperidone antipsychotic treatment in schizophrenia","volume":"34","author":"Cai","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0040","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/j.psyneuen.2013.04.016","article-title":"Comparison of plasma and cerebrospinal fluid levels of neuroactive steroids with their brain: spinal cord and peripheral nerve levels in male and female rats","volume":"38","author":"Caruso","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0045","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1523\/JNEUROSCI.15-06-04641.1995","article-title":"Gas chromatographic-mass fragmentographic quantitation of 3 alpha-hydroxy-5 alpha-pregnan-20-one (allopregnanolone) and its precursors in blood and brain of adrenalectomized and castrated rats","volume":"15","author":"Cheney","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0050","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1111\/j.1460-9568.2009.07013.x","article-title":"Progesterone and allopregnanolone enhance the miniature synaptic release of glycine in the rat hypoglossal nucleus","volume":"30","author":"Chesnoy-Marchais","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0055","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1017\/S1461145710001689","article-title":"3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-na\u00efve patients with schizophrenia","volume":"14","author":"Condray","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0060","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0149-2918(00)80086-7","article-title":"The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia","volume":"22","author":"David","year":"2000","journal-title":"Clin. Ther."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0065","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0006-8993(02)02290-4","article-title":"Depletion of cortical allopregnanolone potentiates stress-induced increase in cortical dopamine output","volume":"932","author":"Dazzi","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0070","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.neuroscience.2003.09.023","article-title":"Allopregnanolone and progesterone decrease cell death and cognitive deficits after a contusion of the rat pre-frontal cortex","volume":"123","author":"Djebaili","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0075","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1089\/neu.2005.22.106","article-title":"The neurosteroids progesterone and allopregnanolone reduce cell death, gliosis, and functional deficits after traumatic brain injury in rats","volume":"22","author":"Djebaili","year":"2005","journal-title":"J. Neurotrauma."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0080","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.yfrne.2009.05.006","article-title":"Neurosteroid biosynthesis: enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides","volume":"30","author":"Do Rego","year":"2009","journal-title":"Front Neuroendocrinol."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0085","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0039-128X(01)00147-7","article-title":"Measurement of steroid sex hormones in serum: a comparison of radioimmunoassay and mass spectrometry","volume":"67","author":"Dorgan","year":"2002","journal-title":"Steroids"},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0090","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archpsyc.1976.01770060086012","article-title":"The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance","volume":"33","author":"Endicott","year":"1976","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0095","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1016\/S0014-2999(98)00285-4","article-title":"Clozapine and olanzapine treatment decreases rat cortical and limbic GABA(A) receptors","volume":"349","author":"Farnbach-Pralong","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0100","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.expneurol.2005.12.013","article-title":"Progesterone administration modulates AQP4 expression and edema after traumatic brain injury in male rats","volume":"198","author":"Guo","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0105","series-title":"ECDEU Assessment Manual for Psychopharmacology, Revised","article-title":"Clinical global impressions","year":"1976"},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0110","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.sbi.2004.04.004","article-title":"Metabolic networks: enzyme function and metabolite structure","volume":"14","author":"Hatzimanikatis","year":"2004","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0115","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.expneurol.2004.06.008","article-title":"Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury","volume":"189","author":"He","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0120","first-page":"449","article-title":"Opposite effects of inhibitory and excitatory neurosteroids on [3H]dopamine release from rat nucleus accumbens","volume":"50","author":"Jaworska-Feil","year":"1998","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0125","series-title":"Applied Multivariate Statistical Analysis, 4th Edn, Upper Saddle River","first-page":"193","author":"Johnson","year":"1998"},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0130","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s00213-002-1006-5","article-title":"The neurosteroid 3\u03b1-hydroxy-5\u03b1-pregnan-20-one affects dopamine-mediated behavior in rodents","volume":"161","author":"Khisti","year":"2002","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0135","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1006\/abio.1999.4384","article-title":"Profiling neurosteroids in cerebrospinal fluids and plasma by gas chromatography\/electron capture negative chemical ionization mass spectrometry","volume":"277","author":"Kim","year":"2000","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0306-4530(02)00128-2","article-title":"Hyperprolactinemia in response to antipsychotic drugs: characterization across comparative clinical trials","volume":"28","author":"Kinon","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0145","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1006\/hbeh.1994.1052","article-title":"Neuroactive steroid actions at the GABAA receptor","volume":"28","author":"Lan","year":"1994","journal-title":"Horm. Behav."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0150","series-title":"Nonparametrics: Statistical Methods Based on Ranks","author":"Lehmann","year":"1975"},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0155","first-page":"143","article-title":"Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction","volume":"74","author":"Lewis","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0160","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10571-006-9086-0","article-title":"The relevance of neuroactive steroids in schizophrenia, depression, and anxiety disorders","volume":"27","author":"MacKenzie","year":"2007","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0165","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0006-3223(99)00305-4","article-title":"Olanzapine increases allopregnanolone in the rat cerebral cortex","volume":"47","author":"Marx","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0170","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/sj.npp.1300952","article-title":"Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics","volume":"31","author":"Marx","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0175","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.pbb.2006.07.026","article-title":"Clozapine markedly elevates pregnenolone in rat hippocampus, cerebral cortex, and serum: candidate mechanism for superior efficacy","volume":"84","author":"Marx","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0180","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.pbb.2006.07.032","article-title":"Olanzapine and fluoxetine administration and coadministration increase rat hippocampal pregnenolone, allopregnanolone and peripheral deoxycorticosterone: implications for therapeutic actions","volume":"84","author":"Marx","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0185","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/npp.2009.26","article-title":"Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia","volume":"34","author":"Marx","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0190","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neuroscience.2011.06.076","article-title":"Pregnenolone as a novel therapeutic candidate in schizophrenia: emerging preclinical and clinical evidence","volume":"191","author":"Marx","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0195","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1007\/s00213-014-3673-4","article-title":"Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia","volume":"231","author":"Marx","year":"2014","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0200","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0031-6997(24)01395-4","article-title":"Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system","volume":"51","author":"Mensah-Nyagan","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0205","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/mp.2012.47","article-title":"Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents","volume":"17","author":"Miyamoto","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0210","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/026988119601000402","article-title":"Inhibition of basal and stress-induced dopamine release in the cerebral cortex and nucleus accumbens of freely moving rats by the neurosteroid allopregnanolone","volume":"10","author":"Motzo","year":"1996","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0215","first-page":"889","article-title":"Hypothesis: minimal changes in neural transmission in schizophrenia: decreased glutamatergic and GABAergic functions in the prefrontal cortex","volume":"29","author":"Ohnuma","year":"2005","journal-title":"Prog Peuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0220","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0225","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2174\/138161211795049589","article-title":"Steroid 5\u03b1-reductase as a novel therapeutic target for schizophrenia and other neuropsychiatric disorders","volume":"17","author":"Paba","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0230","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.euroneuro.2014.07.015","article-title":"Glutamate-mediated excitotoxicity in schizophrenia: a review","volume":"24","author":"Plitman","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0235","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.euroneuro.2006.10.001","article-title":"Differences in blood pregnenolone and dehydroepiandrosterone levels between schizophrenia patients and healthy subjects","volume":"17","author":"Ritsner","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0240","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.expneurol.2005.09.014","article-title":"Physiologic progesterone reduces mitochondrial dysfunction and hippocampal cell loss after traumatic brain injury in female rats","volume":"197","author":"Robertson","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0245","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1460-9568.2002.02084.x","article-title":"The neurosteroid allopregnanolone increases dopamine release and dopaminergic response to morphine in the rat nucleus accumbens","volume":"16","author":"Rouge-Pont","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0250","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.brainres.2009.01.045","article-title":"Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism for better neuroprotective effects of allopregnanolone over progesterone","volume":"1263","author":"Sayeed","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0255","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0260","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0015-0282(16)49094-1","article-title":"Prolactin modulates peripheral androgen metabolism","volume":"45","author":"Serafini","year":"1986","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0265","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0920-9964(01)00367-X","article-title":"Correlation of plasma neurosteroid levels to the severity of negative symptoms in male patients with schizophrenia","volume":"58","author":"Shirayama","year":"2002","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0270","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMoa1411090","article-title":"A clinical trial of progesterone for severe traumatic brain injury","volume":"371","author":"Skolnick","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0275","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/sj.npp.1300460","article-title":"Role of neuroactive steroid allopregnanolone in antipsychotic-like action of olanzapine in rodents","volume":"29","author":"Ugale","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0280","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1038\/jcbfm.2008.73","article-title":"Progesterone and its metabolite allopregnanolone differentially regulate hemostatic proteins after traumatic brain injury","volume":"28","author":"VanLandingham","year":"2008","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0285","doi-asserted-by":"crossref","first-page":"997","DOI":"10.4088\/JCP.08m04508","article-title":"Metabolic risk factors in drug-naive patients with first-episode psychosis","volume":"70","author":"Verma","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0290","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0893-133X(01)00261-5","article-title":"Dopamine D(2) receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects","volume":"25","author":"Wadenberg","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0295","first-page":"28","article-title":"The generalisation of student's problems when several different population variances are involved","volume":"34","author":"Welch","year":"1947","journal-title":"Biometrika"},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0300","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archpsyc.1988.01800320058007","article-title":"A structured interview guide for the hamilton depression rating scale","volume":"45","author":"Williams","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0305","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.mp.4001674","article-title":"Peripheral is central to the question","volume":"10","author":"Wong","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0310","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0006-8993(98)00406-5","article-title":"Nucleus accumbens dopamine release modulation by mesolimbic GABAA receptors-an in vivo electrochemical study","volume":"798","author":"Xi","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.psyneuen.2018.02.004_bib0315","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.brainres.2010.07.046","article-title":"Sprouting of corticospinal tract axons from the contralateral hemisphere into the denervated side of the spinal cord is associated with functional recovery in adult rat after traumatic brain injury and erythropoietin treatment","volume":"1353","author":"Zhang","year":"2010","journal-title":"Brain Res."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453017314488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453017314488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:59:56Z","timestamp":1759683596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453017314488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":63,"alternative-id":["S0306453017314488"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2018.02.004","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnenolone-progesterone-allopregnanolone pathway as a potential therapeutic target in first-episode antipsychotic-na\u00efve patients with schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2018.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}